Epigenetic profiling by ChIP-Seq has become a powerful tool for genome-wide identification of regulatory elements, for defining transcriptional regulatory networks and for screening for biomarkers. However, the ChIP-Seq protocol for low-input samples is laborious, time-consuming and suffers from experimental variation, resulting in poor reproducibility and low throughput.
Introduction
To allow proper function and organization, genomes contain regulatory layers of information generally referred to as the epigenome. The epigenome consists of a wide range of chemical modifications that can be deposited on DNA and histones, such as methylation of DNA or acetylation on histone tails (Kouzarides 2007) . During embryonic and fetal development of mammalian organisms, establishment and maintenance of cellular identity is regulated through these modifications (Berger 2007) . Furthermore, a myriad of diseases is caused or characterized by alteration of epigenetic patterns (Portela and Esteller 2010) . Therefore, epigenetic changes represent a highly interesting layer of information for disease stratification and for personalized medicine (Heyn and Esteller 2012; Dirks et al. 2016) . A plethora of studies have highlighted the role of various histone post-translational modifications (hPTMs) in regulation of chromatin structure necessary for DNA accessibility during gene expression (Jenuwein and Allis 2001; Barski et al. 2007; Berger 2007; Kouzarides 2007; Dekker 2008) . For example, the presence of trimethylation of lysine 4 on histone 3 (H3K4me3) at genomic loci is commonly associated with active promoters (Barski et al. 2007) , while a combination of H3K27 acetylation (H3K27ac) and
H3K4me1 is typical for active enhancers (Creyghton et al. 2010) . As such, it has become clear that epigenetic profiling of hPTMs allows for the identification of regulatory elements in the genome.
During the last ten years, Chromatin ImmunoPrecipitation followed by Sequencing (ChIP-Seq) has become the method-of-choice for genome-wide profiling of transcription factors and hPTMs (Park 2009; Welboren et al. 2009; Collas 2010; Furey 2012) . The ChIP-Seq protocol relies on affinity purification of a DNA-binding protein by the use of antibodies. Characterization of the DNA associated with the protein of interest by Next Generation Sequencing (NGS) allows for identification of the protein binding sites at a genome-wide scale. However, the ChIP-Seq workflow requires large amounts of material, is labor intensive and lacks robustness sue to experimental variation (Ho et al. 2011; Chen et al. 2012; Landt et al. 2012) . These drawbacks make the application of ChIP-seq challenging, in particular in settings where material is limited (Dirks et al. 2016) .
To facilitate ChIP-Seq profiling of low input samples, a range of strategies have been developed (see Fig. S1 for a selection of main strategies (O'Neill et al. 2006; Dahl and Collas 2008b; Dahl and Collas 2008a; Adli and Bernstein 2011; Brind'Amour et al. 2015; Rotem et al. 2015; Schmidl et al. 2015; Dahl et al. 2016 ; van Galen et al. 2016; Weiner et al. 2016; Zhang et al. 2016; Skene et al. 2018; Ai et al. 2019; Kaya-Okur et al. 2019) ). Methods that have been applied include barcoding and pooling of multiple samples in the ChIP reaction (Rotem et al. 2015 ; van Galen et al. 2016; Weiner et al. 2016) , small volume sonication (Adli and Bernstein 2011) , substitution of sonication by a native MNase digestion approach (Brind'Amour et al. 2015) , the use of carrier material (mainly used for ChIP-qPCR) (O'Neill et al. 2006 ) and application of a transposase for DNA cleavage and library generation (Schmidl et al. 2015; Ai et al. 2019; Kaya-Okur et al. 2019) .
Each of the various ChIP-seq methodologies yield incremental benefits, but suffer from (a combination of) low read complexity, lack of robustness, suboptimal throughput and lengthy and/or laborious protocols. On the other hand, semi-automated workflows have been developed to increase reproducibility of ChIP-Seq and reduce the workload of the laborious protocol (Aldridge et al. 2013; Berguet et al. 2014; Gasper et al. 2014; Wallerman et al. 2015) , but these generally require high quantities of input material. Recent studies have shown the feasibility of combining low input samples with automated workflows using microfluidic devices (Cao et al. 2015; Shen et al. 2015; Murphy et al. 2018 ). However, these prototypic platforms require dedicated, custommade sophisticated laboratory equipment, have low throughput due to the limited number of samples that can be run in parallel (1 sample (Cao et al. 2015) , 4 samples (Murphy et al. 2018 ) and 4 samples (Shen et al. 2015) in parallel, respectively) and are mainly focused on few or a single histone modification (H3K4me3). Therefore, despite showing proof-of-principle, further maturation of these platforms in terms of throughput, flexibility and standardization of the microfluidic platform is required to allow integration in workflows of major epigenetic profiling endeavors, such as the International Human Epigenome Consortium (IHEC), but also to allow implementation of these platforms in non-expert laboratories (Bujold et al. 2016; Fernandez et al. 2016; Stunnenberg et al. 2016) . Similarly, throughput and standardization of ChIP-Seq are key for implementation in clinical applications of epigenetic biomarkers.
To enable robust and high-throughput ChIP-Seq on low input samples, we set out to develop a fully automated, integrated ChIP-Seq microfluidic platform. To allow simple and direct integration of our ChIP-Seq workflow in non-specialized molecular biology laboratories, we developed our workflow on a widely available commercial controller for pneumatics and thermocycling, the Fluidigm C1 tm Controller. Although this controller has thus far been mainly used in combination with an integrated fluidic circuits (IFC) device for capturing single cells (Frederickson 2002;  Durruthy-Durruthy and Ray 2018), we designed new polydimethyl siloxane (PDMS)-based microfluidic IFC devices which allows the formation of ChIP bead columns in the 24 parallel reactors insides each device (from here on called plates; Fig 1) . Notably, these IFC plates for ChIP are very different from the IFC plates that have been developed for single cell captures (Durruthy-Durruthy and Ray 2018). After filling the newly developed plates with the appropriate reagents required for the ChIP, the plates can be connected to the controller without any requirement for the user to attach tubing and connectors or engage in programming. The loading of the plate in the controller and further steps of the ChIP up to collection of the ChIP material are fully automated and hence Plug and Play, facilitating consistent and reproducible results between laboratories.
Notably, the hardware of the procedure just consists of the C1 controller together with the readyto-go disposable plates facilitating 24 parallel ChIPs, making it widely accessible.
We show that the automated miniaturized ChIP-Seq workflow that we developed is compatible with as low as 100 cells, with very high reproducibility between parallel input reactors within one plate. For the standard input of the workflow using 15,000 cells as starting material and 3000 cells per ChIP-seq, the platform is compatible with profiling the main hPTMs (H3K4me3, H3K36me3, H3K27ac and H3K4me1) required to assay activity of genes and their associated enhancers. Furthermore, we show the data quality of ChIP-Seq profiles generated by our platform is superior as compared to the quality obtained from prototypical miniaturized ChIP-Seq platforms that have been developed previously. Altogether, we believe our automated Plug and Play (PnP) ChIP-Seq system, which we call PnP-ChIP-Seq, will highly benefit individual non-ChIP expert laboratories doing small numbers of ChIP experiments through core facilities, in addition to enabling largescale projects and consortia. The standardized procedure thereby allows direct comparisons between ChIP-Seq profiles generated in separate laboratories, which have been challenging thus far (Landt et al. 2012) in part due to the large variety in experimental procedures among laboratories. In view of the low-input requirements combined with full standardization of the procedure, our platform might pave the way towards large scale screening of hPTMs as epigenetic biomarkers in clinical settings.
Results

Automated part of ChIP-Seq in microfluidic ChIP workflows
In recent years, a large range of low-input ChIP technologies have been pioneered (Fig. S1 ). These elegant approaches are generally very laborious and prone to multiple sources of noise due to the large number of handling steps. To make these procedures more robust, some of these have been automated in the past (Fig. S1 (Cao et al. 2015; Shen et al. 2015; Murphy et al. 2018) ). Such pioneering work on automation shows proof-of-principle for microfluidic ChIP-Seq, but has been performed on custom-made devices requiring extensive microfluidics and/or ChIP-Seq expertise, while these platforms generally have minimal throughput (maximum of 4 parallel samples) and are focused on a single or very few histone modifications ( Fig. S1 ). Therefore a plug and play ChIP-Seq system for convenient automated processing of large numbers of small-input samples, which is essential in order to obtain consistent and reproducible results of the very widely used ChIP-Seq, is currently lacking. We set out to develop an automated miniaturized low-input ChIP-Seq workflow that can conveniently be adopted by users world-wide by constructing ready-to-go disposable plates for 24 parallel ChIPs to be automatically processed using the Fluidigm C1 tm Controller.
The conventional ChIP workflow ( Fig. S2 ) starts with the collection of chromatin from cells, after which the chromatin is sheared either by enzymatic digestion (for example by the use of MNase) or by ultrasonication. In case of ultrasonication, the chromatin is usually crosslinked before harvesting to stabilize protein-protein and protein-DNA interactions. Next, the isolated chromatin fragments are probed for proteins of interest by antibodies. The antibodies and associated chromatin fragments are captured using a scaffold such as heavy-chain binding beads or resin (for example a mix of Protein A and Protein G antibody binding beads (Prot A/G beads)). After stringent washings to remove non-specific fragments from the scaffold, the DNA fragments are eluted and sequenced to determine the binding sites of the protein of interest at a genome-wide scale. For the microfluidic workflow, we set out to automate the labor-intensive process of (i) coupling the antibody to the beads, (ii) binding of the chromatin to the antibodies, (iii) washing of the antibody-protein complexes that are bound to the beads to remove non-bound background and (iv) elution of the DNA (Fig. 1a & S2) . We designed the workflow such that the DNA that is harvested from the microfluidic plate (in the standard protocol a total of 3 µl) can be directly used as input for DNA library construction required for sequencing, without the need to perform DNA purification.
Microfluidic hardware used for miniaturized ChIP-Seq
For the development of the Integrated Fluidic Circuit (IFC) plates used as hardware for our workflow, we designed polydimethylsiloxane (PDMS) valve-operated fluidic circuits produced using multi-layer soft-lithography (Unger et al. 2000) (Fig. 1b ). The PDMS chip is mounted to a plastic carrier that forms the pneumatic operation interface with commercially available instrumentation (Fluidigm C1 tm ; the chip together with the plastic carrier will be called plate from here on) and contains 25 µl volume inlets and 4 larger reservoirs for reagent loading. The samples, beads, control line fluids as well as wash, harvesting and elution buffers can be conveniently loaded in the appropriate wells of the plate ( Fig. 1b & S3 ). Each IFC plate consists of 24 nanoliterscale parallel reactors that facilitate multiplexing of experiments, while in each reactor a single ChIP experiment is performed (Fig. 1c ). The 24 individual reactors each have individual inputs for At the start of the procedure, all reagents and the dissociated chromatin suspension are loaded into the plate around the microfluidic chip ( Fig. S3 ), after which the entire circuitry is loaded onto the Fluidigm C1 tm and the ChIP protocol is started. All reagents are dead-end filled at the start of a microfluidic run in order to remove any bubbles present in the system while operating. We constructed the procedure such that a tightly packed column of micron-sized monodisperse antibody-binding beads ( Fig. 1a , loading through the green inlet and blue column) is packed on which the immunoprecipitation is performed (Fig. 1d ). This column is built upon a frit layer of inert beads, which are larger in size as compared to the beads used for the column (Fig. 1a & 1c: frit layer schematically represented in cyan at the bottom of the column) and functions to prevent leaking of very small 2.8µm diameter beads through the 5µm-spaced drain at the bottom (Fig. 1a ).
The use of 30% glycerol solution as a carrier keeps the beads in suspension during the process of building the separation columns. After packing the beads, the column is washed using an equilibration buffer to remove any remaining glycerol ( Fig. 1c : flowing through the pink channel).
The chromatin sample, up to 8µl in volume, is flushed across the antibody binding column ( Fig.   1c : flowing through the orange channel). The antibodies used can be loaded together with either the beads or with the chromatin. After binding of the specific chromatin fragments to the antibodies on the bead column, the column is washed using an equilibration buffer followed by a high salt wash buffer ( Fig. 1c : flowing through the pink channel). The specific DNA fragments associated with the protein of interest are eluted using a DNA extraction buffer incubated for 20 minutes at 55°C followed by an hour at 65°C (which decrosslinks when using fixed chromatin and degrades the Proteinase K; Fig. 1c , pink). DNA elution buffer is used to push the eluted DNA fragments to the outlet wells to a final volume of 3µl. This DNA can directly be used for further processing (no clean-up step is needed) since the DNA extraction buffer containing the DNA fragments (~10nl) is highly diluted by the DNA elution buffer. During elution, the resulting DNA fragments are harvested ( Fig. 1c : flow through the harvesting outlet) into individual outlets and can be used for qPCR or sequencing.
Optimization of microfluidic ChIP-qPCR
For optimization of the microfluidic ChIP procedure, we tested a range of variables using ChIP-qPCR on the post-translational histone modification (hPTM) trimethylation of lysine 4 on histone 3 (H3K4me3) in mouse embryonic stem cells (mESCs), including a well-known positive locus of a highly active gene (β-Actin) and a negative locus in a gene-desert for background control as read-out. H3K4me3, which is part of the IHEC reference epigenome set (Barski et al. 2007; Bujold et al. 2016; Fernandez et al. 2016) , is mainly present at promoters of active genes and is used a canonical marker for actively transcribed genes (Barski et al. 2007 ). For testing, the main variables included (i) the composition of the frit layer, (ii) the size of the column used for immunoprecipitation, (iii) the type of beads, and (iv) the pressure used to load the sample on the columns ( Fig. 2a-2d ). For these tests, we used a small quantity of bulk-isolated chromatin to load on each bead column: an amount of chromatin equivalent to 3,000 mESCs. The results showed that a frit layer composed of a mixture of 4.5µm and 6µm inert beads ( Fig. 2a ), combined with large columns (Fig. 2b & S4a ) composed of an equal mix of 2.8µm ProtA and ProtG beads ( Fig.   2c ) resulted in optimal recoveries. The pressure used to load the samples was less critical (Fig. 2d ).
Altogether, these tests resulted in a significant improvement of ChIP-qPCR recoveries as compared to an initial, default workflow that we applied ( Fig. 2e) . Notably, the hands-on time for the optimized microfluidic protocol is very limited, in total around 30 minutes ( Fig. S5a ):
preparation including pipetting of the plate takes at maximum 20 minutes, while harvesting of the 24 ChIP'ed-DNA samples takes another 10 minutes of hands-on time. The hands-free multiplexed immunoprecipitation process that is performed on the bead columns takes approximately 4.5 hours ( Fig. S5 ).
Microfluidic ChIP is sensitive and robust
We next evaluated the performance of the optimize workflow over the 24 individual reactors of a microfluidic chip. The use of our optimized protocol enabled the construction of 24 separate, parallel antibody affinity bead columns on the microfluidic chip ( Fig. S4b ). For ChIP-qPCR, the results obtained for individual columns of a single microfluidic chip were highly consistent, with 40.1% +/-0.15% recovery of H3K4me3 over the Id4 promoter ( Fig. 2f : column A-P). Importantly, the mock controls, in which no chromatin was present, did not show any recovery for either the To evaluate the results of the optimized microfluidic ChIP procedure, we compared our results to conventional ChIP-qPCRs using the equivalent of 500,000 or 10,000 mESCs from a bulk mESC sonicated sample as input. In line with the fact that that lower input quantities affect the efficiency of ChIPs (Kidder et al. 2011; Ku et al. 2019) , we observed a 5-fold reduction in recovery in conventional bench ChIP-qPCRs performed using 10,000 mESCs as compared to the ChIP-qPCRs performed using 500,000 mESCs ( Fig. 2f , left part labeled 1-3). The relative recoveries obtained using the microfluidic ChIP-qPCR procedure using 3,000 mESCs (40.10% +/-0.15%) were much higher as compared to conventional ChIP-qPCRs using chromatin of 10,000 mESCs (7,44% +-0,60%) and also slightly higher than the recoveries obtained for conventional ChIP-qPCRs using chromatin of 500,000 mESCs (37.22% +/-0.46%) ( Fig. 2f ). Altogether, this shows that the miniaturized platform is superior over conventional bench ChIP protocols and sensitive, highly reproducible and efficient in performing ChIPs on very small quantities of cells.
Microfluidic Plug and Play (PnP)-ChIP-Seq for high-quality genome-wide epigenetic profiles of various histone modifications
Next, we used our optimized automated ChIP workflow for ChIP-Seq, a procedure which we dubbed Plug and Play (PnP)-ChIP-Seq. To optimize the PnP-ChIP-Seq we used crosslinked and sonicated chromatin obtained from "bulk" (multi-million) mESC chromatin preparations. We loaded the chromatin equivalent of 3,000, 1,000 and 500 mESCs on the microfluidic platform to generate H3K4me3 ChIP-Seq profiles, with replicate experiments performed on separate microfluidic chips to probe for consistency between runs. Visual inspection shows a high overlap of enriched sites of the low-input PnP-ChIP-Seq profiles as compared to the bulk reference track ( Fig. 3a & S6a) , albeit at lower signal intensities. We next performed peak calling, and plotted the ChIP-Seq signals over the merged peak set. These plots further confirmed the reduction in H3K4me3 signal intensities when using lower number of cells as input, as reflected in the heatmaps ( Fig. 3b ) and average plots ( Fig. S6b ) which show higher signals in conventional bench ChIP-Seq.
However, the Pearson correlation of the intensities of the joint peaks between all different H3K4me3 profiles was very high (r > 0.87), both between bulk ChIP-Seq and PnP-ChIP-Seq as well as between profiles generated by PnP-ChIP-Seq using different input quantities ( Fig. 3c ), confirming the high quality of profiles generated using the microfluidic platform. De novo peak calls on 3000 cell microfluidic ChIP showed that we detected 85% of the bulk reference peakset ( Fig. 3d ), with hardly any peaks being detected outside the bulk reference peakset, while the profiles generated using the chromatin equivalent of 3,000 or 1,000 ESCs show a high overlap ( Fig. 3e ). Furthermore, the ChIP-Seq profiles generated using the microfluidic platform are highly reproducible, as shown by the Pearson correlations ( Fig. 3c ) and by the peak overlap of the replicate H3K4me3 profiles using the chromatin equivalent of 3,000 mESCs (Fig. 3f ).
Besides H3K4me3, we set out to use our platform for profiling of additional hPTMs that are informative for the transcriptional state and potency of cells. In particular we were interested in histone mono-methylation of histone H3 lysine 4 (H3K4me1) and acetylation of histone H3 lysine 27 (H3K27ac), that together allow to define active and poised enhancers (Creyghton et al. 2010) , as well as tri-methylation of histone H3 lysine 36 (H3K36me3), which covers the gene body of active genes (Barski et al. 2007 ). Similar to H3K4me3, these hPTMs are part of the IHEC reference epigenome set for comprehensive profiling of cell types (Barski et al. 2007; Bujold et al. 2016; Fernandez et al. 2016) . For the three additional hPTMs, we used the chromatin equivalent of 3,000 and 1,000 mESCs for PnP-ChIP-Seq. Visual inspection of the profiles generated confirmed the anticipated location of enhancers and active gene bodies, respectively, and also showed the similarity between the bulk reference track and the PnP-ChIP-Seq tracks (Fig. 3a & S6a) . Similar to H3K4me3, H3K4me1 and H3K27ac show a reduction in signal associated with the number of cells used as input for the PnP-ChIP-Seq (Fig. 3b ). Further analysis using correlograms showed the PnP-ChIP-Seq tracks of H3K4me1, H3K27ac and H3K36me3 were well in concordance with ChIP-Seq tracks using bulk material, albeit the Pearson's correlations were somewhat lower as compared to the profiles generated for H3K4me3 (Fig. 3c ). The majority of peaks called for H3K4me1, H3K27ac and H3K36me3 were also present in the bulk reference set, with between 65% and 76% of the bulk peaks being called (Fig. 3d ). The use of 1000 mESCs resulted in a clear drop in signals: although for H3K27ac we were still able to call most of the peaks as present in the bulk reference set, this number dropped to 30% and 56% for H3K36me3 and H3K4me1, respectively (Fig. 3e) . Altogether, these analyses show the compatibility of our microfluidic platform to profile the main epigenetic hPTM marks associated with gene activity using very low sample quantities of 3000 mESCs, while the use of a lower number of mESCs generally results in a loss of sensitivity.
PnP-ChIP-seq is compatible with low abundant populations of cells
Having established the sensitivity of our platform on small quantities of chromatin prepared from bulk collections, we set out to make the microfluidic platform compatible with ChIP-Seq profiling of low-abundant populations of cells that are not easily collected in large amounts. The preparation of chromatin from a low number of cells is challenging, in particular when using sonication for chromatin shearing. We extensively tested sonication on low quantities of cells, but this resulted in a gradual loss of ChIP-Seq signal when reducing the amount of input chromatin used for shearing ( Fig. S7a & S7b) . Therefore, we switched to low-input MNase digestion for shearing of chromatin. We took a fixed number of 15,000 mESCs for MNase digestions, and subsequently used the chromatin equivalent of 3,000, 1,000, 500 and 100 mESCs for H3K4me3 ChIP-Seq as input for the microfluidic platform ( Fig. 4a & S8a) . Visual inspection showed the H3K4me3 PnP-hIP-Seq profiles were very similar to the bulk reference profiles generated by conventional ChIP-Seq (using 2 million mESCs), independent of the number of mESCs loaded on the platform. Peak calling on the individual profiles showed a high overlap of peak calls between the bulk reference set and the H3K4me3 PnP-ChIP-Seq profiles generated using the 3,000 mESC chromatin equivalent (Fig. 4b) . The use of a smaller number of mESCs resulted in a drop in the number of peaks called for H3K4me3, with 85% and 71% of peaks from the bulk peakset detected for the chromatin equivalent of 1,000 and 500 mESCs, respectively. But even with as few as 100 mESC chromatin equivalent, we were still able to call 53% of the peaks as present in bulk H3K4me3
ChIP-Seq (Fig. 4b) . The drop in peak calls for the small quantities was mainly caused by a concentration-dependent decrease of H3K4me3 signals (Fig. 4c & S8b) , which is known for low input ChIP-Seq (Kidder et al. 2011; Ku et al. 2019) . Notably, even though we started with only 15,000 mESCs in the MNase-based protocol, the H3K4me3 PnP-ChIP-Seq profiles showed higher signal-to-noise ratios compared to the H3K4me3 PnP-ChIP-Seq profiles generated using chromatin that was sonicated in bulk ( Fig. S8b cf Fig. S6b ). Quantification of the merged H3K4me3 peak set of the MNase-based profiles showed a very high correlation (Fig. 4d) , with cross-correlations between low cell-input experiments and the bulk reference of r > 0.82 (Pearson correlation), further underlining the high quality of the ChIP-Seq profiles generated by the microfluidic platform. Importantly, the consistency between technical replicates, separated before MNase treatment, was high, as shown by Pearson correlation using the common peaks (r > 0.88; Fig. 4d ) and by overlap of the peak calls for which the majority of peaks were consistently detected in all replicates irrespective of the number of mESCs that was used as input for the PnP-ChIP-Seq (Fig. S8c) .
To further evaluate the performance of the PnP-ChIP-Seq, we performed comparative analysis to other low-input ChIP-Seq technologies that have been developed and have included H3K4me3
ChIP-Seq on mESCs in their studies, in particular ChIP-Seq profiles of 1,000 mESCs on a previously developed prototype microfluidic platform (Shen et al. 2015) and low-input native ChIP-Seq profiles generated using the ULI-NChIP-Seq bench protocol (Brind'Amour et al. 2015) .
In terms of the number of peak calls, our microfluidic ChIP-Seq compared favorably with ULI-NChIP-Seq, and is comparable to the prototypic microfluids platform (Fig. S9a ). However, in terms of signal-to-noise ratio (Fig. S9b ) and similarity to the bulk reference ( Fig. S9c) , our PnP-ChIP-Seq was shown to be superior to both methods that were previously developed.
In view of the high sensitivity of the PnP-H3K4me3 ChIP-Seq profiles, we included H3K4me1, H3K27ac and H3K36me3 for further profiling of the mESCs, using the chromatin equivalent of 3,000 mESCs (obtained from an MNase treated sample of 15,000 mESCs). Visual inspection of the profiles generated using the microfluidic platform confirmed the anticipated location, and also showed the similarity between the bulk reference track and the PnP-ChIP-Seq profiles (Fig. 4a &   S8a ). Although the similarity to bulk ChIP-Seq for these hPTMs was somewhat lower as compared to H3K4me3, the Pearson correlation of r > 0.58 (Fig. S10a) , the heatmap over the peaks (Fig. 4c) and the overlap of peaks as compared to bulk native ChIP-Seq (Fig. S10b) showed that the PnP-ChIP-Seq profiles were of very good quality. Although the signal intensities of H3K27ac of the 3000 ESCs were reduced as compared to the bulk (Fig. 4c) , peak calling identified around half of the H3K27ac enriched sites (Fig. S10b) . Also, the 3000 mESC profiles of H3K4me1, H3K27ac and H3K36me3 showed good reproducibility (Fig. 4c, 4d & S10c). In conclusion, these experiments show that by the use of 15,000 cells, we were able to perform comprehensive epigenetic profiling (H3K4me3, H3K4me1, H3K27ac and H3K36me3) using PnP-ChIP-Seq in an automated fashion.
Totipotent subpopulations as present in mESC populations are similar to other mESCs in the population
Having established a sensitive method to perform ChIP-Seq profiling on low abundant cell populations, we set out to study totipotent cells that are present within mESC cultures. mESC cultures are heterogeneous (Kolodziejczyk et al. 2015) , and it was previously shown that a small number of mESCs within the total mESC population represent totipotent cells or "2 cell-stage like" (2C-like) cells (Morgani and Brickman 2014) . However, it is currently unclear whether such subpopulations emerge in a stochastic fashion and whether this is accompanied by epigenetic changes. To further characterize the totipotent cells, we performed fluorescent-activated cell sorting (FACS) for distinct low-abundant subpopulations of mESCs, as previously reported, based on promoter activity of Hhex (Morgani et al. 2013; Morgani and Brickman 2014) , Zscan4c (Falco et al. 2007; Macfarlan et al. 2012; Eckersley-Maslin et al. 2016; Ishiguro et al. 2017) and MuERV-L (MERVL) (Macfarlan et al. 2012; Eckersley-Maslin et al. 2016) . We made use of fluorescent reporters in three different ESC lines: (i) a Venus-positive subpopulation of mESCs sorted using a Hhex::Venus reporter, that has been shown to be totipotent (Morgani et al. 2013; Brickman 2014); (ii) an Emerald-GFP-positive subpopulation of mESCs sorted using a Zscan4c::Emerald-GFP reporter, that has been reported to be 2C-like cells (Falco et al. 2007; Macfarlan et al. 2012; Eckersley-Maslin et al. 2016; Ishiguro et al. 2017) ; and (iii) a TdTomatopositive population of mESCs sorted using a MERVL::TdTomato reporter, which is a subselection of the Zscan4-positive mESC population (Macfarlan et al. 2012; Eckersley-Maslin et al. 2016) ( Fig. 5a ). The FACS profiles showed that we were able to collect discrete subpopulations of mESCs based on their fluorescent markers (Fig. S11) . We validated the sorting by comparing expression of the marker-positive populations versus expression of the marker-negative populations using RT-qPCR. We detected increased RNA expression of the sorted subpopulation marker as well as the corresponding fluorescent transcript and multiple other specific markers for the subpopulations as reported in the original studies ( Fig. 5b) (Morgani et al. 2013; Eckersley-Maslin et al. 2016) , confirming that we obtained the anticipated subpopulations of totipotent cells.
Next, we used PnP-ChIP-seq to profile H3K4me3 for the mESCs populations showing Hhex, Zscan4c and MERVL promoter activity by means of positive marker expression, as well as for the populations of mESCs that were negative for the markers (Fig. 5c & 5d ). Visual inspection of the H3K4me3 profiles showed that the Venus, Emerald-GFP and TdTomato-positive mESCs were similar to their negative counterparts (Fig 5c) , including the H3K4me3 signals at the promoters of the core pluripotency factors Nanog, Oct4 and Sox2 (Fig. 5d ). Next, we quantified genome-wide enrichment of promoter-associated H3K4me3. We observed a very high correlation between the Venus, Emerald-GFP and TdTomato-positive mESC subpopulations as compared to their respective negative mESC subpopulations (Fig. 5e ). Strikingly, statistical analysis for differential H3K4me3 sites showed that none of the H3K4me3 enriched sites in the three subpopulations of totipotent or 2C-like cells was significant different from the remainder of the populations of the respective mESCs (FDR-adjusted p-value <0.05; Fig. 5e ). Therefore, the transcriptional changes associated with the 2C-or totipotent state (Falco et al. 2007; Macfarlan et al. 2012; Morgani et al. 2013; Eckersley-Maslin et al. 2016 ) are apparently not reflected in the H3K4me3 epigenetic landscape. This suggests that propagation of the expanded potential of mESCs in the 2C-or totipotent state might occur by a stochastic increase in transcriptional activity of genes associated with totipotency rather than by stable epigenetic (H3K4me3-associated) alterations. Correlation of H3K4me3 signal in promoters between marker-positive mESCs (totipotent mESC subpopulations) and marker-negative mESCs; no differential sites were detected (fdr.adj.p<0.05).
Discussion
Determining protein binding sites on DNA by means of ChIP-seq is key to our understanding of gene regulation (Jenuwein and Allis 2001; Barski et al. 2007; Berger 2007; Kouzarides 2007; Dekker 2008; Park 2009; Portela and Esteller 2010) . Furthermore, it has important potential for identification of epigenetic biomarkers for disease stratification and personalized medicine (Heyn and Esteller 2012; Dirks et al. 2016) . To facilitate such studies, the compatibility of ChIP-Seq with low cell quantity input is highly beneficial to enable the use of relevant biological specimens, for example mouse early embryonic tissues or human biopsies. With respect to epigenetic biomarker discovery and screening, it is essential that the ChIP-Seq protocol is sensitive, robust and highthroughput with little hands-on time. For large scale studies and routine clinical use, it is important to minimize variation among users and between laboratories. With the development of Plug and Play ChIP-seq, we achieved reproducible, robust low-input ChIP reactions for 24 sample in parallel with only 30 minutes of hands-on time on disposable plates. The procedure that we pioneered is automated and standardized, therefore no prior knowledge of microfluidics nor ChIP-Seq is required to setup or run the ChIP-Seq application. Therefore, the PnP-ChIP-Seq can conveniently be applied in non-expert laboratories, provided that these have access to the Fluidigm C1 tm Controller. Also, the automation and parallelization of the low-input ChIP protocol as reported here paves the way towards large-scale ChIP-Seq profiling of precious sample types.
Because traditional ChIP-Seq approaches require large amounts of material (Ho et al. 2011; Chen et al. 2012; Landt et al. 2012 ), a range of previous studies such as have worked towards procedures to downscale the ChIP procedure ( Fig S1 (O 'Neill et al. 2006; Dahl and Collas 2008b; Dahl and Collas 2008a; Adli and Bernstein 2011; Brind'Amour et al. 2015; Rotem et al. 2015; Schmidl et al. 2015; Dahl et al. 2016; van Galen et al. 2016; Weiner et al. 2016; Zhang et al. 2016; Skene et al. 2018; Ai et al. 2019; Kaya-Okur et al. 2019) ). These include barcoding and pooling of multiple samples in the ChIP reaction (Rotem et al. 2015; van Galen et al. 2016; Weiner et al. 2016 ) the use of carrier material (O'Neill et al. 2006 ) and application of a transposase for DNA cleavage and library generation (Schmidl et al. 2015; Ai et al. 2019 ). Furthermore, single-cell ChIP-Seq approaches have been developed, such as single-cell CUT&RUN The flexibility of our platform, in terms of (i) the reagents to be loaded; (ii) the fully flexible circulation schemes of reagents due to the large number of independent control valves; and (iii) the control over the temperature, will further facilitate to automate the alternative ChIP approaches using our PnP-ChIP-Seq. In view of the better performance of our microfluidic platform as compared to low-input bench ChIP (Fig 2f) and previously developed microfluidic platforms (Fig.   S9 ), the use of the PnP-ChIP-Seq might further increase the sensitivity of these procedures.
While previous studies that engineered miniaturization of ChIP-Seq mainly focused on H3K4me3 (Cao et al. 2015; Shen et al. 2015; Murphy et al. 2018 ), we set out to perform PnP-ChIP-Seq for H3K4me3, H3K36me3, H3K27ac and H3K4me1, all of which are part of the IHEC set of reference epigenomes (Bujold et al. 2016; Fernandez et al. 2016 ). By starting with as few as 15,000 cells for MNase treatment and 3,000 cells per ChIP reaction, the PnP-ChIP-Seq allows for profiling of these four hPTMs thereby obtaining a comprehensive overview of the transcriptional status of cells.
Low-input cell numbers affect sensitivity of ChIPs (Kidder et al. 2011; Ku et al. 2019) , which is clear in the current study from the H3K4me3 average profiles ( Fig S8) .
However, the use of 3000 mESCs allowed for the detection of the majority of enriched sites for H3K4me3, H3K4me1 and H3K36me3. Although profiling of H3K27ac appeared to be more challenging, similar to previous observations (Murphy et al. 2018) , the PnP-ChIP-Seq still allowed for detection of around half of the total number of enriched sites. The lower performance for H3K27ac might be related to the affinity of the antibody, the availability of the H3K27ac epitope, the distribution of H3K27ac over the genome or the total levels of H3K27ac present in mESCs.
Depending on these variables, we anticipate that our platform is likely to be compatible with profiling of other hPTMs that we did not include in this study. Notably, profiling of Transcription Factors (TFs) is known to be generally more delicate than profiling of hPTMs (Park 2009; Furey 2012) . TFs are generally profiled using crosslinked chromatin to stably capture the binding event of TFs to chromatin or DNA. In view of the fact that we make use of MNase for shearing of the chromatin, which is not easily compatible with crosslinked chromatin, profiling of TFs by the use of PnP-ChIP-Seq is likely to be challenging. However, a recent study showed the feasibility to perform ChIP-Seq profiling of TFs on non-crosslinked chromatin by the use of MNase using a method called ORGANIC (Kasinathan et al. 2014) . Therefore PnP-ChIP-Seq may also be useful for analysis of transcription factors and other non-histone proteins.
To gain mechanistic insight, we apply PnP-ChIP-Seq to study totipotent or 2C-like cells that are present within mESC cell cultures. By comparison of H3K4me3 ChIP-Seq of the totipotent cell population versus the remainder of the (non-totipotent/ pluripotent) mESC population, we set out to investigate whether the totipotent cells arise due to stochastic gene activation in mESCs or due to epigenetic activation of genes by means of deposition of H3K4me3. As we do not find significant changes in H3K4me3 between totipotent cells and the remainder of the mESC population, using either Zscan, MERVL or Hhex promoter activity as marker for totipotency, we tentatively conclude that the totipotent cells likely arise in the mESC population due to stochastic gene activation. Notably, our findings do not exclude the possibility that the totipotent state contains unique chromatin features other than related to H3K4me3, for example at the level of DNA methylation (Macfarlan et al. 2012; Morgani and Brickman 2014; Eckersley-Maslin et al. 2016) . Taken together, our results provide a solid rationale for the observations that mESCs rapidly cycle in and out of the totipotent or 2C-like state (Macfarlan et al. 2012; Morgani and Brickman 2014) . The absence of a robust epigenetic program of transcription being activated likely results in a rapid downregulation of the totipotency genes after their activation in mESCs.
Altogether, the universal ChIP device as pioneered in the current study will facilitate implementation of the labor-intensive and highly sensitive low-input ChIP procedure in regular laboratories with no expertise in the ChIP procedure. Moreover, given the highly parallelized, automated workflow, the PnP-ChIP workflow will find its way to specialized epigenetic laboratories and core facilities enabling large-scale projects and consortia. In view of the reproducibility and sensitivity, the robustness of the procedure and the low-input requirements, we anticipate that the PnP-ChIP-Seq will be a first step to discovery and screening of hPTM-based biomarkers in the clinic (Martens et al. 2010; Ross-Innes et al. 2012; Saeed et al. 2012; Jansen et al. 2013; Stelloo et al. 2015; Cejas et al. 2016; Dirks et al. 2016) . Whether in a research setting or in the clinic, implementation of PnP-ChIP-Seq will benefit from the fact that our workflow is based on commercially available Fluidigm C1 tm microfluidic platform. However, we anticipate that the protocol presented here can also be easily adapted to other programmable microfluidic platforms with a similar design, namely nanoliter-sized affinity purification columns targeting chromatinassociated proteins with pressure-driven laminar flow of buffers and lysates. 
Methods
Conventional ChIP
Chromatin extracts were prepared by on-plate cell crosslinking in 1% paraformaldehyde for 8 minutes. Crosslinking was quenched using 125 mM (final concentration) freshly dissolved glycine.
Fixed cells were washed in PBS twice, then collected by scraping. Pellets were lysed and sonicated in 50 mM Tris pH 8.0, 1% SDS and fresh protease inhibitor cocktail (Roche) at a density of 15 million cells per milliliter. The cells were sonicated in a Bioruptor Pico (Diagenode) for eight to ten 30-second cycles. Proper sonication was evaluated using agarose gel size checks after decrosslinking. DNA concentrations were quantified using the Qubit HS (Thermo Fischer Scientific). The sonicated chromatin was diluted 9-fold using IP buffer (consisting of 1% 
Low-input microfluidic ChIP
Crosslinked chromatin was prepared from a cell suspension according to the conventional protocol as described above, with volumes downscaled to match the concentrations of cells used. For lowvolume sonication, we used a 5.5 µL volume custom prototype shearing device. For native ChIP-Seq, non-crosslinked chromatin of 15,000 mESCs was digested using MNase (NEB M0247) for 5-15 minutes at 20°C, after which the quality of the digestion was checked on a Bioanalyzer (Agilent). After digestion, the chromatin was diluted two-fold in 60mM Tris pH8.0, 300mM NaCl, 1µg/µL antibody and 2x protease inhibitor cocktail (freshly prepared). For microfluidic ChIP, final volumes were kept below 20µL to ensure short loading times across the pre-packed antibody affinity bead column. Both crosslinked as well as native chromatin was snap frozen in liquid blacklist ). Bedtools v2.20.1 and pybedtools were used for peak call intersections and tag counting on peaks or promoter regions. For the H3K4me3 analysis of totipotent cells or "2 cell-stage like" (2C-like) cells, DESeq2 regularized log transformation and differential analysis was performed on 1kb regions around all promoters, using a cutoff >10 read normalized tags per H3K4me3 promoter (Anders and Huber 2010) . Heatmaps and average profiles were created using ngsplot v2.61. (C) Overlap between de novo H3K4me3 peak calls of replicate PnP-ChIP-seq using small cell quantities by the use of MNase shearing on 15,000 mESCs.
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